Literature DB >> 27154148

Timing and Frequency of Unplanned Readmissions After Lung Transplantation Impact Long-Term Survival.

Entela Lushaj1, Walker Julliard1, Shahab Akhter1, Glen Leverson1, James Maloney1, Richard D Cornwell2, Keith C Meyer2, Nilto DeOliveira3.   

Abstract

BACKGROUND: Adverse events that require hospital readmission frequently occur long after lung transplantation (LT) that has been successfully performed. We sought to identify the causes and rate of unplanned readmissions after LT and to determine whether unplanned readmissions have a significant impact on post-LT survival.
METHODS: We retrospectively reviewed the outcomes in 174 LT recipients who underwent LT at our center from June 2005 to May 2014. The median follow-up period was 38 months (range, 17 to 72 months).
RESULTS: One hundred sixty (92%) of the 174 recipients were readmitted 854 times (5.3 times per patient). The median time to first readmission was 71 days (interquartile range [IQR], 28 to 240 days), and the median hospital length of stay at readmission was 3 days (IQR, 2 to 6 days). Freedom from first readmission was observed for 65% of patients at 1 month, 48% at 3 months, 43% at 6 months, and 26% at 12 months. Gender, lung allocation score, body surface area, year of transplantation, air leak longer than 5 days after operation, and allograft function were risk factors for readmission. The causes of readmission included infections (33%), respiratory adverse events (18%), rejection (15%), gastrointestinal events (15%), renal dysfunction (5%), and cardiac events (4%). Patients who died were found to have had early readmissions (p = 0.04) and more frequent readmissions (p = 0.001).
CONCLUSIONS: The first year after LT remains a high-risk period for unplanned readmissions regardless of pretransplantation diagnosis. Readmissions soon after discharge at index hospitalization and multiple readmissions are associated with an increased risk of mortality.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27154148     DOI: 10.1016/j.athoracsur.2016.02.083

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Patterns of Hospital Performance on the Hospital-Wide 30-Day Readmission Metric: Is the Playing Field Level?

Authors:  Erik H Hoyer; William V Padula; Daniel J Brotman; Natalie Reid; Curtis Leung; Diane Lepley; Amy Deutschendorf
Journal:  J Gen Intern Med       Date:  2017-10-02       Impact factor: 5.128

2.  Causes, Preventability, and Cost of Unplanned Rehospitalizations Within 30 Days of Discharge After Lung Transplantation.

Authors:  Andrew M Courtwright; Derek Zaleski; Lisa Gardo; Vivek N Ahya; Jason D Christie; Maria Crespo; Denis Hadjiliadis; James Lee; Maria Molina; Namrata Patel; Mary Porteous; Edward E Cantu; Christian Bermudez; Joshua M Diamond
Journal:  Transplantation       Date:  2018-05       Impact factor: 4.939

3.  Remote Therapy to Improve Outcomes in Lung Transplant Recipients: Design of the INSPIRE-III Randomized Clinical Trial.

Authors:  James A Blumenthal; Patrick J Smith; Andrew Sherwood; Stephanie Mabe; Laurie Snyder; Courtney Frankel; Daphne C McKee; Natalie Hamilton; Francis J Keefe; Sheila Shearer; Jeanne Schwartz; Scott Palmer
Journal:  Transplant Direct       Date:  2020-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.